Industry Partnerships & Commercialization
The Industry Partnerships and Commercialization (IP&C) Office at The Hospital for Sick Children (SickKids) champions the identification, development, and commercialization of cutting-edge health innovations from SickKids researchers, partnering with industry and investors to translate these innovations into impactful healthcare services and products worldwide.
Transforming SickKids Innovation into Global Health Impact
At IP&C, our team comprises individuals with deep scientific expertise and extensive experience in patenting, licensing, commercial transactions, and startup ventures.
We go beyond traditional tech transfer roles by assisting SickKids Innovators in de-risking their discoveries, maximizing their value, and aligning with investor interests.
Discover how we connect ideas, industry, and investors to create efficient commercialization pathways at SickKids!
Latest News
SickKids Scientist Receives $1M Transformative Research Award to Advance Huntington’s Disease Treatment SickKids IP&C is excited to congratulate Dr. Christopher Pearson, Senior Scientist in the Genetics & Genome Biology program at [...]
Now Accepting Applications for the 2025 Proof of Principle Grant Competition Are you a SickKids researcher developing a therapeutic, diagnostic, or medical device with potential for real-world impact? The SickKids Industry [...]
Celebrating World IP Day with the Launch of the SickKids Technology Portfolio In celebration of World Intellectual Property (IP) Day this past weekend, the Industry Partnerships & Commercialization (IP&C) office [...]
AWARD ANNOUNCEMENT SickKids’ Dr. Jennifer Stinson Receives Gairdner Momentum Award for Transforming Paediatric Pain Care We’re thrilled to celebrate Dr. Jennifer Stinson, Nurse Practitioner, Senior Scientist, and long-time innovator [...]
